Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is an aggressive cancer with a high rate of death globally. The use of bioinformatics may help to identify immune cell-related genes both as targets for potential immunotherapies...
Source: Cancer Cell International - Category: Cancer & Oncology Authors: Chen Xue, Xinyu Gu and Lanjuan Li Tags: Primary research Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Genetics | Hepatocellular Carcinoma | Immunotherapy | Liver Cancer